Transdiagnostic Internet- and mobile-based intervention for the prevention of depression and anxiety
Not Applicable
- Conditions
- Subclinical depression and subclinical anxietyF32F41.9F41.1F41.0Depressive episodeAnxiety disorder, unspecifiedGeneralized anxiety disorderPanic disorder [episodic paroxysmal anxiety]
- Registration Number
- DRKS00011099
- Lead Sponsor
- ehrstuhl für Klinische Psychologie und Psychotherapie (KliPs) Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 566
Inclusion Criteria
Signed consent form, subclinical symptoms of a common mental health disorder (depression, anxiety) based on self-disclosure questionnaires (depression: CES-D=16; anxiety: GAD=5)
Exclusion Criteria
Clinical depression and/or anxiety disorder, determined by clinical interviews;
Suicidality at baseline, measured by BDI II, item 9 (value > 1);
Unwilling to sign the consent form;
Diagnosed psychosis or dissociative symptoms;
bipolare disorder in the past or present;
On waiting list for psychotherapy;
Psychotherapeutical treatment because of depression or anxiety in the last 6 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to disorder onset of any depression and/or anxiety disorder within a follow-up period of 12 months after baseline, determined by clinical, diagnostic telephone interviews:<br>• Psychopathology (Sections of Mini international Neuropsychiatric Interview, Mini 6.0, Sheehan, Lecrubier, 2010) at T1 baseline (pre), 6 and 12 months Follow-up (6 & 12 M-F-U);<br>• Depressive symptoms (Inventory of depressive Symptomatology QIDS-C16, Rush, et al., 1996), at pre, post, 6 & 12 M-F-U;<br>• Anxiety symptoms (Hamilton Anxiety Rating Scale, HAM-A, Hamilton, 1959), at pre, post, 6 & 12 M-F-U.
- Secondary Outcome Measures
Name Time Method